Next-Generation Sequencing Reveals the Potential Role of RET Protooncogene in Metastasis Progression in Medullary Thyroid Cancer

Next-Generation Sequencing Reveals the Potential Role of RET Protooncogene in Metastasis Progression in Medullary Thyroid Cancer

<b>Background:</b> Medullary thyroid carcinoma (MTC) has a high rate of local and distant metastases. In particular, the RET protooncogene appears to be the predominant driver mutation for oncogenesis. The German S3 thyroid carcinoma guidelines recommend molecular genetic analysis of the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maurice Klein, Anna Julia Claudia Klein, Arnold M. Raem, Nicklas Garrelfs, Henrike J. Fischer, Frank Hölzle, Kai Wermker
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Current Issues in Molecular Biology
Subjects:	MTC thyroid cancer metastasis medullary thyroid cancer RET
Online Access:	https://www.mdpi.com/1467-3045/47/7/560
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Familial Clinical Heterogeneity of Medullary Thyroid Cancer with Germline RET S891A Protooncogene Mutation: 7-year Follow-up with Successful Sorafenib Treatment
by: Sirmen Kızılcan Çetin, et al.
Published: (2025-09-01)

A Comparative Study on the Multidimensional Features of Hereditary and Sporadic Medullary Thyroid Carcinoma Patients: A Single-Center Retrospective Study
by: Muzaffer Serdar Deniz, et al.
Published: (2025-06-01)

Selpercatinib – a new option for a precision approach to the treatment of medullary thyroid cancer
by: A. K. Plugar, et al.
Published: (2024-12-01)

THE DIAGNOSIS AND TREATMENT OF MEDULLARY THYROID CANCER
by: V. Zh. Brzhezovsky, et al.
Published: (2015-04-01)

Medullary Thyroid Carcinoma Detected by Routine Health Screening Had Better Clinical Outcome and Survival
by: Ji Hyun Yoo, et al.
Published: (2025-06-01)

Sonographic manifestations of multiple medullary carcinoma coexisting with papillary carcinoma of the thyroid: A case report
by: Yuang Xie, BM, et al.
Published: (2025-06-01)

p.M918W, a novel RET germline variant: a case report and literature review of the possible association of multiple endocrine neoplasia type 2B and Charcot-Marie-Tooth disease
by: Mami Sato, et al.
Published: (2025-07-01)

Breast metastasis from medullary thyroid carcinoma: a report of a case
by: Yoko Omi, et al.
Published: (2021-08-01)

Disseminated medullary thyroid carcinoma. Optimal approach to treatment
by: I. S. Romanov, et al.
Published: (2019-01-01)

SPORADIC MEDULLARY THYROID CANCER. СASE REPORT
by: L. A. Ivanova, et al.
Published: (2015-04-01)

Simultaneous medullary thyroid carcinoma and primary non-small cell lung cancer: case report and literature review
by: Zhang Jianyong, et al.
Published: (2025-07-01)

A Unique Case of Medullary Thyroid Carcinoma in the Background of Hashimoto's Thyroiditis
by: Allahdad Khan, et al.
Published: (2025-04-01)

Complexities in diagnosis and treatment of medullary thyroid cancer. Clinical observation
by: E. V. Frolova, et al.
Published: (2024-10-01)

Surgical treatment of a patient with multiple endocrine neoplasia type 2A
by: T. A. Britvin, et al.
Published: (2020-11-01)

Medullary thyroid cancer in combination with autoimmune thyroiditis after COVID-19
by: E. V. Ryabchenko
Published: (2022-06-01)

Efficacy of vandetanib in the treatment of medullary thyroid cancer: literature review and case report
by: А. М. Mudunov, et al.
Published: (2019-10-01)

Preoperative identification of the risk factors of cervical lymph node metastasis in medullary thyroid carcinoma
by: Yitong Wang, et al.
Published: (2025-08-01)

Activation of the AKT-mTOR pathway confers selpercatinib resistance in thyroid cancer cells harboring the CCDC6-RET fusion gene
by: Masatsugu Amitani, et al.
Published: (2025-09-01)

Efficacy of external beam radiotherapy and targeted therapy with vandenanib in patients with inoperable and progressive medullary thyroid cancer
by: A. D. Kaprin, et al.
Published: (2018-11-01)

Analysis of treatment outcomes in patients with progressive locally advanced non-resectable and disseminated medullary thyroid cancer receiving vandetanib outside of clinical trials (Russian experience)
by: I. S. Romanov, et al.
Published: (2020-07-01)

All-cause mortality in patients with medullary thyroid carcinoma of different ages: an inverse L-curve analysis study
by: Jiahua Chen, et al.
Published: (2025-06-01)

Role of the calcium stimulation test in diagnosing medullary thyroid cancer: is it adequate to achieve a diagnosis in both sexes? An individual patient data meta-analysis
by: Franz Sesti, et al.
Published: (2025-05-01)

Measurement of calcitonin and cea in the needle washout fluid from thyroid nodule for the diagnosis of medullary thyroid carcinoma
by: N. V. Severskaya, et al.
Published: (2023-11-01)

Celastrol promotes apoptotic cell death in thyroid cancer cells through a caspases-dependent pathway
by: Ruoyi Yang, et al.
Published: (2025-02-01)

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
by: Sena Turkdogan, et al.
Published: (2018-09-01)

Recurrence of Sipple syndrome
by: O.V. Safonova, et al.
Published: (2025-05-01)

Navigating the complexity of current interventional radiological approaches for distant metastases in thyroid cancer
by: Daqi Zhang, et al.
Published: (2025-07-01)

Possibilities of single photon emission tomography in the diagnosis of bone metastases in patients with disseminated medullary thyroid carcinoma (case report)
by: E. E. Stanyakina, et al.
Published: (2019-07-01)

Use of selpercatinib in a patient with <i>RET</i>-mutated non-small cell lung cancer: case report
by: A. M. Kazakov, et al.
Published: (2024-05-01)

Comparing the Diagnostic Efficacy of Different Calcitonin Stimulation Tests for Sporadic Medullary Thyroid Carcinoma: Calcium Gluconate vs. Calcium Chloride
by: Jovan Ilic, et al.
Published: (2025-07-01)

Morbidity patterns and long-term outcomes of central lymph node dissection in thyroid cancer patients
by: Khalid Atallah, et al.
Published: (2025-07-01)

The utility of 68Ga-DOTATATE and 18F-FDG PET/CT in predicting the response to tyrosine kinase inhibitors in patients with advanced medullary thyroid cancer
by: Eline C. Jager, et al.
Published: (2025-06-01)

GENERAL ASPECTS OF THE DIAGNOSIS AND TREATMENT OF LOCALLY ADVANCED THYROID CANCER
by: L. P. Yakovleva, et al.
Published: (2015-04-01)

Tumor Mutation Burden Survey of AACR GENIE Database Revealed NTRK (NTRK+) and RET (RET+) Fusions Positive Colorectal Carcinoma (CRC) as Distinct Subsets
by: Zhaohui Liao Arter, et al.
Published: (2025-02-01)

Clinicopathological observation and prognostic factors of invasive breast cancer with medullary in Xinjiang
by: Yan Li, et al.
Published: (2025-07-01)

Very low thyroglobulin level and rare metastatic location in radio-iodine refractory DTC should raise suspicion for initial misdiagnosis
by: Seyed Rasoul Zakavi, et al.
Published: (2025-06-01)

MEDULLARY THYROID CARCINOMA
by: V. S. Medvedev, et al.
Published: (2015-04-01)

RET podría actuar como un gen supresor de tumores en células de cáncer de cuello uterino
by: Mariana A. Martínez-Castillo, et al.
Published: (2025-04-01)

Study of nuclear morphometry in the cytologic evaluation of thyroid neoplasms
by: Joyce Thomas, et al.
Published: (2023-12-01)

Clinical experience in the neoadjuvant treatment of unresectable differentiated thyroid cancer with the lenvatinib
by: E. B. Vasilyeva, et al.
Published: (2024-06-01)